- Home
- GPRE vs EVMN Comparison
GPRE vs EVMN Comparison
Compare GPRE & EVMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GPRE | EVMN |
|---|---|---|
| Founded | 2004 | 2020 |
| Country | United States | United States |
| Employees | N/A | 48 |
| Industry | Major Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 812.2M | 825.5M |
| IPO Year | 2004 | N/A |
Fundamental Metrics
Financial Performance| Metric | GPRE | EVMN |
|---|---|---|
| Price | $15.67 | $22.10 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 10 |
| Target Price | $12.57 | ★ $43.88 |
| AVG Volume (30 Days) | ★ 1.3M | 308.6K |
| Earning Date | 05-07-2026 | 06-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.42 | N/A |
| Revenue | ★ $2,091,680,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $11.85 | N/A |
| P/E Ratio | $38.63 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.97 | $13.89 |
| 52 Week High | $18.94 | $33.20 |
Technical Indicators
Market Signals| Indicator | GPRE | EVMN |
|---|---|---|
| Relative Strength Index (RSI) | 42.43 | 41.98 |
| Support Level | $14.84 | $21.39 |
| Resistance Level | $16.80 | $23.08 |
| Average True Range (ATR) | 0.92 | 1.42 |
| MACD | -0.20 | -0.21 |
| Stochastic Oscillator | 3.55 | 25.45 |
Price Performance
Historical ComparisonAbout GPRE Green Plains Inc.
Green Plains Inc manufactures and sells ethanol and ethanol byproducts in two segments based on function. The ethanol production segment, which generates the majority of revenue, includes the production of ethanol, distillers grains, Ultra-High Protein and renewable corn oil. The agribusiness and energy services segment includes grain handling and storage, commodity marketing and merchant trading for company-produced and third-party ethanol, distillers grains, Ultra-High Protein, renewable corn oil, natural gas and other commodities.
About EVMN Evommune Inc.
Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.